Nicole Ireland / theglobeandmail - About three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and many more would like to
Back to Top / Tuesday, March 3, 2026, 11:21 am / permalink 20069 / 4 stories in 3 days
Novo Nordisk eyes generics with lower-priced renamed drugs / 1 month
Generic Ozempic production approved in Canada / 2 months
Canada approves first oral HIV self-test for at-home use / 24 days
Canadian Tire fined $1.3M for misleading advertising practices / 28 days
CPPIB invests $750M in Northleaf mid‐market push / 7 wks
Health Canada greenlights first postpartum depression pill for treatment / 2 months
Competition Bureau clears EQB’s proposed acquisition of PC Financial / 10 hrs
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.